New dialysis filter may improve survival – but study is only observational

NCT ID NCT07561424

Recruiting now Knowledge-focused Sponsor: Arbor Research Collaborative for Health Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether a new type of dialysis filter (medium cut-off dialyzer) helps kidney patients live longer and have fewer complications compared to standard filters. Researchers will review medical records from 1,000 adults on maintenance dialysis. The study is observational, meaning it watches what happens in real-world care rather than assigning treatments, so it can suggest but not prove benefits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: medium cut-off (MCO) dialyzer (Theranova)
What this could lead to: If MCO dialyzers show better survival or fewer complications, this could point toward a new standard for dialysis care.
What could go wrong: This is an observational study, not a controlled trial, so results may be influenced by other factors. It cannot prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIALYSIS PATIENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIALYSIS PATIENTS ESKD

Contacts and locations

Locations

AURA
RECRUITING

Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.